Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab with Bendamustine or Chlorambucil in CLL (MaBLe)
NCT01056510Phase 4Completed
- Sponsor
- Roche
- Start
- Mar 2010
- Primary completion
- Mar 2014
- Modality
- Monoclonal Antibodies
- Countries
- 8
01
Overview
A Phase 4 trial of rituximab in chronic lymphocytic leukemia (CLL), sponsored by Roche. Started Mar 2010; status: completed.
02
Drugs
rituximab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01056510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01056510.